For the period up to March 31st institutional ownership for Ziopharm is reported at 56,804,195 shares or 43% of the 132,000,000 outstanding. That's as per Nasdaq's site using the most recent 13F filings.
75 institutions reported selling 9,478,065 shares, and 78 reported buying 5,399,666 shares for a net decrease of 4,078,399. 31 institutions reported selling out completely a total of 4,959,092 shares while there were 23 new positions reported for 2,116,425 shares. That's a net difference of 2,842,667 shares favoring those selling out.
The biggest seller was the University of Texas Investment Management Co, or UTIMCO for short. They chose to sell their remaining 2,503,575 shares, all that was left from the 11.7 million shares they received for "choosing" to partner with Ziopharm.
I know there are some who probably think UTIMCO had no choice but to sell, thanks to some false information posted to Seeking Alpha by a blogger with the User Name Options2Wealth. In a SA instablog this writer said that UTIMCO was obligated to sell the shares because of a charter mandate.
Allow me to set the record straight on that score.
This error of thinking that UTIMCO was mandated to dispose of their shares in ZIOP comes from this link:
Therein it deals with securities distributed to certain endowment funds, the PUF and GEF funds, standing for Permanent University Fund and General Endowment Fund respectively. Ziopharm however filed their own 8K dated May 5th 2015 explaining how and when the shares might be sold. The 8K states:
Discretion, for those unaware, means an option or choice. In other words there was no mandate to sell the shares because they weren't distributed to the PUF or GEF funds. UTIMCO excercised their discretionary power and "decided" to sell out of their holdings in Ziopharm.
Why? UTIMCO represents itself as having an "Equity Bias". That means they prefer holding equities to other investment vehicles. Why they decided they didn't want to continue holding their Ziopharm shares though, I don't know.
I would strongly recommend reading the entire filing for those who mistakenly thought UTIMCO had no choice but to sell. And to those who told UTIMCO "had" to sell, if you want to apologise for your error when I posted about this previously, the comment field is open.
Perhaps Options2Wealth will post a correction on Seeking Alpha. That would be the right thing to do in my opinion, unless of course he willingly misrepresented the facts in the hopes of pumping up the share price, in which case I won't hold my breath.
Perhaps Options2Wealth will post a correction on Seeking Alpha. That would be the right thing to do in my opinion, unless of course he willingly misrepresented the facts in the hopes of pumping up the share price, in which case I won't hold my breath.
Joe, you are one crazy obsessed nut; just pull up Google Finance and see a chart comparison of KITE and ZIOP and how closely they followed each other the last year, except the larger dip in January due to some misunderstanding about the UT stock sale, but in March & April, they are nearly identical until (I suppose) the garbage attack articles on Intrexon. Your newest blog article is also as irrelevant as other blog article you have written. So, tell me please, name any small or medium cap biotech that UTIMCO has in their portfolio that they hold of such size as the ZIOP or XON positions that they once held. Did you know that they only had to hold the stock for 4 months by requirement of the deal??? Also, if not for awful macro conditions and fear of stuff like interest rates and Hillary B.S. we could easily be hitting new highs versus where we are. So, are you going to go on the attack of JUNO & CLLS or even the XBI for also being down 30% in the past year? (Just insane your repetition getting you nowhere). Oh I know, I know, you will come back and say, "what about those that got trapped in at $12 to $14?" - Ok, so how do you know that those are poor people and/or did not get stopped out? And you harp on Institutional holdings lower, but if they are just worried about macro and not necessarily this biotech in particular, they can also end up wrong. In fact as ZIOP rose from $3 to $10 and then higher, guess what......Fidelity (FMR) had sold out of all of this holdings of ZIOP prior to the big MDA deal that Jan of 2015. It's like for the whole last year, no matter the price, you post blog articles, post nearly every hour on StockTwits, and yahoo message board I hear, and some on Twitter - for what? Have you made much money? Gee, I shorted DNDN, MNKD, and many others, but I don't hang around like a child on such message boards to make myself feel better about it - man, you are one insecure nut for sure. Oh, and guess what, I personally complained to StockTwits site cause of your blatant attempts at manipulation of the stock price (which is illegal in the USA - not Canada?) & they told me via email (since I am not on the site personally, that, "nearly all the members on the site have you and your 2 handles, Growacet & JSTockPick on ignore!".....lol. Too funny - just wasting your life away and everyone knows it! Get a life dude cause no one cares.
ReplyDeleteYou should learn to use paragraphs, would make your ranting more readable.
ReplyDeleteFWIW I only use one ID on Stocktwits, growacet...and one on yahoo, krill66. Sorry...I realize you're used to manipulative liars and distorters but that's not my game.
No one cares? That really hurts :-) But you obviously care, cheers.
Did you notice how I used spaces between my sentences?